Inventor · disambiguated record
Richard T. Coughlin
Also filed as: COUGHLIN RICHARD T
10 granted patents·1 pending application·316 citations·filing 1990–2021
92Inventor score
Top patents by PatentIndex Score
11 records- 0193US6204252B1Characterization of granulocytic ehrlichia and methods of useAQUILA BIOPHARM INC·Filed 1998·Granted Mar 20, 2001·64 cites·23 claims
- 0290US8093008B2Characterization of granulocytic ehrlichia and methods of useMURPHY CHERYL·Filed 2010·Granted Jan 10, 2012·8 cites·15 claims
- 0388US8435495B2Characterization of granulocytic Ehrlichia and methods of useMURPHY CHERYL·Filed 2012·Granted May 7, 2013·5 cites·15 claims
- 0484US5231003AMonoclonal antibodies specific for toxin b of clostridium difficileCAMBRIDGE BIOSCIENCE CORP·Filed 1990·Granted Jul 27, 1993·63 cites·9 claims
- 0582US6284238B1Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methodsAQUILA BIOPHARM INC·Filed 1995·Granted Sep 4, 2001·57 cites·6 claims
- 0678US6306394B1Nucleic acids, proteins, and methods of use of granulocytic ehrlichiaAQUILA BIOPHARM INC·Filed 1998·Granted Oct 23, 2001·53 cites·9 claims
- 0776US8461323B2Characterization of granulocytic ehrlichia and methods of useMURPHY CHERYL·Filed 2012·Granted Jun 11, 2013·3 cites·21 claims
- 0876US6794181B2Method of purifying lantibioticsIMMUCELL CORP·Filed 2002·Granted Sep 21, 2004·6 cites·11 claims
- 0974US5976860ACell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methodsAQUILA BIOPHARM INC·Filed 1996·Granted Nov 2, 1999·53 cites·34 claims
- 1063US7863434B2Characterization of granulocytic Ehrlichia and methods of useANTIGENICS INC·Filed 2001·Granted Jan 4, 2011·4 cites·29 claims
- 1145US2021263047A1Biomarker, methods, and compositions thereof for evaluation or management of kidney function or diagnosing or aid in diagnosing kidney dysfunction or kidney diseaseSEQUELA INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard T. Coughlin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →